Trial intelligence / Profile preview

Zostavax in living donor kidney transplant patients

NCT00940940Phase 4Completed

Sponsor
University of Alberta
Start
Oct 2009
Primary completion
Aug 2013
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 4 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by University of Alberta. Started Oct 2009; status: completed.

02

Drugs

zoster vaccine, live
03

Conditions

herpes zoster (HZ)

Beyond the preview

Go deeper on NCT00940940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00940940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call